• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素笔与胰岛素瓶及注射器:临床和经济结果的差异

Insulin pens vs. vials and syringes: differences in clinical and economic outcomes.

作者信息

Bastian Michael D, Wolters Nicholas E, Bright David R

机构信息

The Raabe College of Pharmacy, Ohio Northern University, Ada, Ohio.

出版信息

Consult Pharm. 2011 Jun;26(6):426-9. doi: 10.4140/TCP.n.2011.426.

DOI:10.4140/TCP.n.2011.426
PMID:21628141
Abstract

Insulin therapy is crucial to the treatment of many patients with diabetes mellitus. Therefore, it is important for pharmacists to consider the clinical and economic implications of the decision between insulin pens and insulin vials and syringes. Clinically, insulin pens show an advantage through improved adherence and reduced hypoglycemic events. Furthermore, overall health care costs were either unchanged or improved in insulin pen users as compared with those using insulin vials and syringes, although little economic advantage was observed when switching from insulin vials to insulin pens. Patients tend to prefer insulin pen use based on patient satisfaction and ease of use. Through an understanding of the advantages and disadvantages of insulin pens and vials and syringes, pharmacists can help to advocate for the most appropriate insulin-delivery method to maximize clinical outcomes and to reduce overall health care spending.

摘要

胰岛素治疗对于许多糖尿病患者的治疗至关重要。因此,药剂师考虑胰岛素笔与胰岛素瓶和注射器之间选择的临床和经济影响很重要。在临床上,胰岛素笔通过提高依从性和减少低血糖事件显示出优势。此外,与使用胰岛素瓶和注射器的患者相比,胰岛素笔使用者的总体医疗保健成本要么没有变化,要么有所改善,尽管从胰岛素瓶改用胰岛素笔时几乎没有观察到经济优势。基于患者满意度和易用性,患者倾向于更喜欢使用胰岛素笔。通过了解胰岛素笔以及胰岛素瓶和注射器的优缺点,药剂师可以帮助倡导最合适的胰岛素给药方法,以最大限度地提高临床疗效并减少总体医疗保健支出。

相似文献

1
Insulin pens vs. vials and syringes: differences in clinical and economic outcomes.胰岛素笔与胰岛素瓶及注射器:临床和经济结果的差异
Consult Pharm. 2011 Jun;26(6):426-9. doi: 10.4140/TCP.n.2011.426.
2
Insulin pens vs. vials and syringes: the pharmacist's role in individualizing therapy.胰岛素笔与药瓶和注射器:药剂师在个体化治疗中的作用。
Consult Pharm. 2011 Jul;26(7):491-3. doi: 10.4140/TCP.n.2011.491.
3
Considerations for diabetes: treatment with insulin pen devices.关于糖尿病的考虑因素:胰岛素笔装置治疗。
Am J Ther. 2013 Nov-Dec;20(6):694-702. doi: 10.1097/MJT.0b013e318217a5e3.
4
Empowering people with diabetes: improving perceptions and outcomes with technical advances in insulin pens.为糖尿病患者赋能:借助胰岛素笔的技术进步改善认知和结果。
Postgrad Med. 2012 Sep;124(5):110-20. doi: 10.3810/pgm.2012.09.2587.
5
Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization.住院期间使用笔式装置或注射器注射胰岛素的患者满意度及相关费用。
Am J Health Syst Pharm. 2008 Jul 15;65(14):1347-57. doi: 10.2146/ajhp070636.
6
Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.瓶/注射器与笔式装置的健康经济学和合规性:证据回顾。
Diabetes Technol Ther. 2010 Jun;12 Suppl 1:S101-8. doi: 10.1089/dia.2009.0180.
7
Addressing barriers to insulin therapy: the role of insulin pens.解决胰岛素治疗障碍:胰岛素笔的作用。
Am J Ther. 2011 Sep;18(5):392-402. doi: 10.1097/MJT.0b013e3181ef4dde.
8
Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.医疗补助计划覆盖的2型糖尿病患者开始胰岛素笔治疗后的医疗费用及药物依从性:一项回顾性数据库分析
Clin Ther. 2007 Jun;29(6 Pt 1):1294-305. doi: 10.1016/j.clinthera.2007.07.007.
9
The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study.使用餐时胰岛素笔与胰岛素瓶和 2 型糖尿病患者的医疗费用及资源利用的关联:一项回顾性队列研究。
J Med Econ. 2013 Oct;16(10):1231-7. doi: 10.3111/13696998.2013.823091. Epub 2013 Jul 23.
10
Nurse satisfaction using insulin pens in hospitalized patients.住院患者使用胰岛素笔的护士满意度。
Diabetes Educ. 2009 Sep-Oct;35(5):799-809. doi: 10.1177/0145721709340057. Epub 2009 Jul 24.

引用本文的文献

1
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin 70/30 with US-licensed HUMULIN® 70/30 formulation in healthy subjects: Results from the RHINE-3 (Recombinant Human INsulin Equivalence-3) study.在健康受试者中,Biocon 的生物类似药胰岛素 70/30 与美国许可的 Humulin® 70/30 制剂的药代动力学和药效学等效性:RHINE-3(重组人胰岛素等效性 3)研究结果。
Diabetes Obes Metab. 2022 Sep;24(9):1819-1828. doi: 10.1111/dom.14768. Epub 2022 Jun 6.
2
Comparison of patient preference for two insulin injection pen devices in relation to patient dexterity skills.患者对两种胰岛素注射笔装置的偏好与患者操作技能的比较。
J Diabetes Sci Technol. 2012 Jul 1;6(4):910-6. doi: 10.1177/193229681200600423.
3
Analysis of patient satisfaction with a prefilled insulin injection device in patients with type 1 and type 2 diabetes.
1型和2型糖尿病患者对预填充胰岛素注射装置的满意度分析。
J Diabetes Sci Technol. 2011 Sep 1;5(5):1235-7. doi: 10.1177/193229681100500532.